Role of 6-O-sulfated heparan sulfate in chronic renal fibrosis

Journal of Biological Chemistry

Volumn 289, Issue 29, 2014, Pages 20295-20306

  Alhasan, Abd A ^a   Spielhofer, Julia ^a   Kusche Gullberg, Marion ^b   Kirby, John A ^a   Ali, Simi ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES;

CHRONIC REJECTION; DOWN-REGULATION; EPITHELIAL CELLS; GROWTH FACTOR; HEPARAN SULFATES; IDURONIC ACID; RENAL EPITHELIAL CELLS; RENAL FIBROSIS;

HYDRAULIC STRUCTURES;

6 O SULFATED HEPARAN SULFATE; DISACCHARIDE; FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE; HEPARAN SULFATE 6 O ENDOSULFATASE; IDURONIC ACID 2 O SULFATED DISACCHARIDE; IDURONIC ACID MONO 2 O SULFATED DISACCHARIDE; MEMBRANE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MONO 6 O SULFATED DISACCHARIDE; SULFATASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE ANALYSIS; CELL STIMULATION; CHRONIC DISEASE; CHRONIC GRAFT REJECTION; CHRONIC KIDNEY FIBROSIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VIVO STUDY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY EPITHELIUM; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SULFATION;

FIBROBLAST GROWTH FACTOR (FGF); FIBROSIS; HEPARAN SULFATE; SULFOTRANSFERASE; TRANSPLANTATION;

ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTOR 2; FIBROSIS; GRAFT REJECTION; HEPARITIN SULFATE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SULFATES; SULFOTRANSFERASES;

EID: 84904497396     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.554691     Document Type: Article

References (44)

1. Zeisberg, M., and Neilson, E. G. (2010) Mechanisms of tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 21, 1819-1834
2. Lindahl, U., Kusche-Gullberg, M., and Kjellén, L. (1998) Regulated diversity of heparan sulfate. J. Biol. Chem. 273, 24979-24982 (Pubitemid 28443251)
3. Esko, J. D., and Selleck, S. B. (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71, 435-471 (Pubitemid 34800227)
4. Allen, B. L., and Rapraeger, A. C. (2003) Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly. J. Cell Biol. 163, 637-648 (Pubitemid 37429875)
5. Feyzi, E., Saldeen, T., Larsson, E., Lindahl, U., and Salmivirta, M. (1998) Age-dependent modulation of heparan sulfate structure and function. J. Biol. Chem. 273, 13395-13398 (Pubitemid 28268375)
6. Jayson, G. C., Lyon, M., Paraskeva, C., Turnbull, J. E., Deakin, J. A., and Gallagher, J. T. (1998) Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J. Biol. Chem. 273, 51-57 (Pubitemid 28042175)
7. Ai, X., Do, A. T., Lozynska, O., Kusche-Gullberg, M., Lindahl, U., and Emerson, C. P., Jr. (2003) QSulf1 remodels the 6-O-sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J. Cell Biol. 162, 341-351 (Pubitemid 36928846)
8. Rosen, S. D., and Lemjabbar-Alaoui, H. (2010) Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate. Expert Opin. Ther. Targets 14, 935-949
9. Sugaya, N., Habuchi, H., Nagai, N., Ashikari-Hada, S., and Kimata, K. (2008) 6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture. J. Biol. Chem. 283, 10366-10376
10. Schlessinger, J., Plotnikov, A. N., Ibrahimi, O. A., Eliseenkova, A. V., Yeh, B. K., Yayon, A., Linhardt, R. J., and Mohammadi, M. (2000) Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 6, 743-750
11. Ali, S., Hardy, L. A., and Kirby, J. A. (2003) Transplant immunobiology: a crucial role for heparan sulfate glycosaminoglycans? Transplantation 75, 1773-1782 (Pubitemid 36734630)
12. Born, J., Jann, K., Assmann, K. J., Lindahl, U., and Berden, J. H. (1996) N-Acetylated domains in heparan sulfates revealed by a monoclonal antibody against the Escherichia coli K5 capsular polysaccharide. Distribution of the cognate epitope in normal human kidney and transplant kidney with chronic vascular rejection. J. Biol. Chem. 271, 22802-22809 (Pubitemid 26304728)
13. Rienstra, H., Katta, K., Celie, J. W., van Goor, H., Navis, G., van den Born, J., and Hillebrands, J. L. (2010) Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats. PloS ONE 5, e9095
14. Joosten, S. A., van Dixhoorn, M. G., Borrias, M. C., Benediktsson, H., van Veelen, P. A., van Kooten, C., and Paul, L. C. (2002) Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat. Am. J. Pathol. 160, 1301-1310 (Pubitemid 34411634)
15. Busse, M., Feta, A., Presto, J., Wilén, M., Grønning, M., Kjellén, L., and Kusche-Gullberg, M. (2007) Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation. J. Biol. Chem. 282, 32802-32810 (Pubitemid 350159291)
16. Dennissen, M. A., Jenniskens, G. J., Pieffers, M., Versteeg, E. M., Petitou, M., Veerkamp, J. H., and van Kuppevelt, T. H. (2002) Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies. J. Biol. Chem. 277, 10982-10986 (Pubitemid 34952854)
17. Robertson, H., Ali, S., McDonnell, B. J., Burt, A. D., and Kirby, J. A. (2004) Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition. J. Am. Soc. Nephrol. 15, 390-397 (Pubitemid 38140779)
18. Wang, S., Ai, X., Freeman, S. D., Pownall, M. E., Lu, Q., Kessler, D. S., and Emerson, C. P., Jr. (2004) QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 101, 4833-4838 (Pubitemid 38469163)
19. Lai, J., Chien, J., Staub, J., Avula, R., Greene, E. L., Matthews, T. A., Smith, D. I., Kaufmann, S. H., Roberts, L. R., and Shridhar, V. (2003) Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer. J. Biol. Chem. 278, 23107-23117 (Pubitemid 36830377)
20. Celie, J. W., Katta, K. K., Adepu, S., Melenhorst, W. B., Reijmers, R. M., Slot, E. M., Beelen, R. H., Spaargaren, M., Ploeg, R. J., Navis, G., van der Heide, J. J., van Dijk, M. C., van Goor, H., and van den Born, J. (2012) Tubular epithelial syndecan-1 maintains renal function in murine ischemia/reperfusion and human transplantation. Kidney Int. 81, 651-661
21. Yue, X., Li, X., Nguyen, H. T., Chin, D. R., Sullivan, D. E., and Lasky, J. A. (2008) Transforming growth factor-β1 induces heparan sulfate 6-Oendosulfatase 1 expression in vitro and in vivo. J. Biol. Chem. 283, 20397-20407
22. Feyzi, E., Lustig, F., Fager, G., Spillmann, D., Lindahl, U., and Salmivirta, M. (1997) Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain. J. Biol. Chem. 272, 5518-5524 (Pubitemid 27102374)
23. Lyon, M., Deakin, J. A., Mizuno, K., Nakamura, T., and Gallagher, J. T. (1994) Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J. Biol. Chem. 269, 11216-11223
24. Smeds, E., Habuchi, H., Do, A.-T., Hjertson, E., Grundberg, H., Kimata, K., Lindahl, U., and Kusche-Gullberg, M. (2003) Substrate specificities of mouse heparan sulphate glucosaminyl 6-O-sulphotransferases. Biochem. J. 372, 371-380 (Pubitemid 36723882)
25. Habuchi, H., Miyake, G., Nogami, K., Kuroiwa, A., Matsuda, Y., Kusche-Gullberg, M., Habuchi, O., Tanaka, M., and Kimata, K. (2003) Biosynthesis of heparan sulphate with diverse structures and functions: two alternatively spliced forms of human heparan sulphate 6-O-sulphotransferase-2 having different expression patterns and properties. Biochem. J. 371, 131-142 (Pubitemid 36458087)
26. van Kuppevelt, T. H., Dennissen, M. A., van Venrooij, W. J., Hoet, R. M., and Veerkamp, J. H. (1998) Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J. Biol. Chem. 273, 12960-12966 (Pubitemid 28246857)
27. Lamanna, W. C., Baldwin, R. J., Padva, M., Kalus, I., Ten Dam, G., van Kuppevelt, T. H., Gallagher, J. T., von Figura, K., Dierks, T., and Merry, C. L. (2006) Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity. Biochem. J. 400, 63-73 (Pubitemid 44763820)
28. Tátrai, P., Egedi, K., Somorácz, A., van Kuppevelt, T. H., Ten Dam, G., Lyon, M., Deakin, J. A., Kiss, A., Schaff, Z., and Kovalszky, I. (2010) Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer. J. Histochem. Cytochem. 58, 429-441
29. Rops, A. L., van den Hoven, M. J., Baselmans, M. M., Lensen, J. F., Wijnhoven, T. J., van den Heuvel, L. P., van Kuppevelt, T. H., Berden, J. H., and van der Vlag, J. (2008) Heparan sulfate domains on cultured activated glomerular endothelial cells mediate leukocyte trafficking. Kidney Int. 73, 52-62 (Pubitemid 350273635)
30. Masola, V., Gambaro, G., Tibaldi, E., Brunati, A. M., Gastaldello, A., D'Angelo, A., Onisto, M., and Lupo, A. (2012) Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. J. Biol. Chem. 287, 1478-1488
31. Strutz, F., and Zeisberg, M. (2006) Renal fibroblasts and myofibroblasts in chronic kidney disease. J. Am. Soc. Nephrol. 17, 2992-2998 (Pubitemid 44707759)
32. Jastrebova, N., Vanwildemeersch, M., Rapraeger, A. C., Giménez-Gallego, G., Lindahl, U., and Spillmann, D. (2006) Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors. J. Biol. Chem. 281, 26884-26892 (Pubitemid 44401717)
33. Mohammadi, M., Olsen, S. K., and Goetz, R. (2005) A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs. Curr. Opin. Struct. Biol. 15, 506-516 (Pubitemid 41393481)
34. Mulloy, B., and Rider, C. C. (2006) Cytokines and proteoglycans: an introductory overview. Biochem. Soc. Trans. 34, 409-413 (Pubitemid 43953999)
35. Dai, Y., Yang, Y., MacLeod, V., Yue, X., Rapraeger, A. C., Shriver, Z., Venkataraman, G., Sasisekharan, R., and Sanderson, R. D. (2005) HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. J. Biol. Chem. 280, 40066-40073 (Pubitemid 41779141)
36. Guimond, S., Maccarana, M., Olwin, B. B., Lindahl, U., and Rapraeger, A. C. (1993) Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J. Biol. Chem. 268, 23906-23914 (Pubitemid 23335365)
37. Kamimura, K., Koyama, T., Habuchi, H., Ueda, R., Masu, M., Kimata, K., and Nakato, H. (2006) Specific and flexible roles of heparan sulfate modifications in Drosophila FGF signaling. J. Cell Biol. 174, 773-778 (Pubitemid 44373727)
38. Do, A. T., Smeds, E., Spillmann, D., and Kusche-Gullberg, M. (2006) Overexpression of heparan sulfate 6-O-sulfotransferases in human embryonic kidney 293 cells results in increased N-acetylglucosaminyl 6-O-sulfation. J. Biol. Chem. 281, 5348-5356 (Pubitemid 43847628)
39. Ai, X., Do, A. T., Kusche-Gullberg, M., Lindahl, U., Lu, K., and Emerson, C. P., Jr. (2006) Substrate specificity and domain functions of extracellular heparan sulfate 6-O-endosulfatases, QSulf1 and QSulf2. J. Biol. Chem. 281, 4969-4976 (Pubitemid 43847759)
40. Chevalier, R. L., Forbes, M. S., and Thornhill, B. A. (2009) Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 75, 1145-1152
41. van den Born, J., Salmivirta, K., Henttinen, T., Ostman, N., Ishimaru, T., Miyaura, S., Yoshida, K., and Salmivirta, M. (2005) Novel heparan sulfate structures revealed by monoclonal antibodies. J. Biol. Chem. 280, 20516-20523 (Pubitemid 40776752)
42. Ten Dam, G. B., Kurup, S., van de Westerlo, E. M., Versteeg, E. M., Lindahl, U., Spillmann, D., and van Kuppevelt, T. H. (2006) 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J. Biol. Chem. 281, 4654-4662 (Pubitemid 43847724)
43. Lensen, J. F., Rops, A. L., Wijnhoven, T. J., Hafmans, T., Feitz, W. F., Oosterwijk, E., Banas, B., Bindels, R. J., van den Heuvel, L. P., van der Vlag, J., Berden, J. H., and van Kuppevelt, T. H. (2005) Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodies. J. Am. Soc. Nephrol. 16, 1279-1288 (Pubitemid 41716512)
44. Wong, W. K., Robertson, H., Carroll, H. P., Ali, S., and Kirby, J. A. (2003) Tubulitis in renal allograft rejection: role of transforming growth factor-β and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells. Transplantation 75, 505-514 (Pubitemid 36241148)